A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) Tablet

Clinical trial NCT03808493 · COMPLETED

Trial details

NCT number: NCT03808493
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Japanese Healthy Adult Male

Start date: 2019-01-30
Primary completion: 2019-03-12
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.